SUMMARY
INTRODUCTION
Matrix metalloproteinases (MMPs) play a central role in the turnover of the extracellular matrix as well as the processing of numerous proteins (1) (2) (3) (4) (5) (6) . These zinc endopeptidases are produced as latent proteins; hence, mechanisms that convert pro-MMPs to catalytically active MMPs are essential for regulating enzyme function. Once activated, MMPs can be inactivated by endogenous tissue inhibitors of metalloproteinases (TIMPs) (5) or by internalization (7, 8) .
During regulated proteolysis, a balance exists between activation and inhibition of MMPs.
Dysregulation of this balance is implicated in the pathogenesis of a variety of diseases, such as atherosclerosis, aneurysm formation, emphysema, and tumor growth and metastasis (1) (2) (3) (4) (5) (6) 9) .
The MMP prodomain contains a highly conserved thiol residue within the consensus sequence PRCXXPD (5) . In the inactive state, this conserved thiol binds to the zinc atom of the catalytic domain preventing the latent enzyme from becoming inappropriately active. A pro-MMP can be activated in vitro by proteolytic cleavage of its prodomain, which releases the thiolzinc interaction, and consequently freeing the catalytic site to interact with substrate. However, activation of pro-MMPs can be mediated by processes that disrupt the thiol-zinc interaction, and it is likely that proteolysis is not the sole mechanism controlling MMP activity (10).
Reactive oxygen and nitrogen species can regulate MMP activity in vitro (11) (12) (13) (14) , suggesting that generation of such species by inflammatory cells (15, 16) control MMP activation and inactivation in vivo. Myeloperoxidase, a heme protein secreted by neutrophils, monocytes, and some populations of macrophages, is one potential source of reactive oxygen and nitrogen species (17, 18) . This enzyme uses hydrogen peroxide (H 2 O 2 ) to generate hypochlorous acid (HOCl) (19). HOCl is a potent cytotoxic oxidant that converts pro-collagenase-2 (MMP-8), pro-gelatinase B (MMP-9), and pro-matrilysin (MMP-7) into their proteolytically active forms (11, 20, 21) . HOCl reacts rapidly and nearly quantitatively with thioethers and thiols (22) (23) (24) . Tryptophan residues in proteins also appear to be important targets for damage (25) . Therefore, HOCl might control MMP activity by covalently modifying key amino acid residues in the enzyme (26).
Pro-MMP-7, pro-MMP-8, and pro-MMP-9 exposed to increasing concentrations of HOCl initially increase their proteolytic activities (11, 20, 21) . We recently demonstrated that HOCl converts the thiol residue of the cysteine switch domain of pro-MMP-7 to the corresponding sulfinic acid (21) . Thiol oxidation is associated with autolytic cleavage of pro-MMP-7, strongly suggesting that oxygenation activates the latent enzyme. We have proposed that this pathway plays a critical role the rupture of atherosclerotic lesions (21, 27 ). These observations suggest that
HOCl provides an oxidative mechanism for activating latent MMPs in vascular disease (28).
Myeloperoxidase's oxidative footprints have been found in human disorders ranging from atherosclerosis to lung disease, indicating that HOCl contributes to tissue damage during inflammation (29) . However, hypercholesterolemic mice deficient in myeloperoxidase develop more atherosclerosis than do wild-type mice (30) , and MMPs can be inactivated by reactive intermediates (12, 14, 31) , suggesting that myeloperoxidase may also restrain pathological tissue injury. In the current studies, we potential mechanisms for enzyme inactivation and demonstrate that HOCl, but not H 2 O 2 , oxidizes methionine and tryptophan residues of active MMP-7. When a specific tryptophan is converted to a novel oxidation product, the active enzyme loses catalytic activity. These observations reveal a molecular mechanism for inactivating MMPs. Fluorescence (λ ex = 328 nm, λ em = 392 nm) was monitored using a microplate reader (SPECTRAmax GEMINI XS; Molecular Devices; Sunnyvale, CA).
RESULTS

HOCl inactivates MMP-7.
To determine whether oxidants inactivate MMP-7 in vitro, we exposed activated enzyme to HOCl or H 2 O 2 for 30 min at 37°C in buffer B. Then we determined whether MMP-7 could cleave Mca, a synthetic fluorescent peptide. MMP-7 exposed to increasing concentrations of HOCl lost its proteolytic activity (Fig. 1) . Zymographic analysis of MMP-7 with casein also showed that the enzyme lost activity when it was exposed to HOCl.
MMP-7 was inactivated by the complete myeloperoxidase system, consisting of enzyme, H 2 O 2 , and chloride ion (data not shown). In contrast, the same concentrations of H 2 O 2 did not inhibit the proteolytic activity of MMP-7 ( Fig. 1 ). These observations indicate that HOCl generated by myeloperoxidase can convert active MMP-7 to an enzymatically inactive form.
HOCl oxidizes specific residues in MMP-7.
To investigate the molecular basis for the oxidative inactivation of MMP-7, we first digested unmodified enzyme with trypsin and identified the resulting peptides through LC-MS and MS/MS analysis (Fig. 2) . The 11 peptides detected by LC-MS accounted for 92% of the protein's sequence. Importantly, they included all the amino acid residues of MMP-7 known to be highly susceptible to oxidation by HOCl or H 2 O 2 (tryptophan (W) and methionine (M); peptides 1, 8, 10, and 11). Because of poor retention on the HPLC column, we were unable to identify small peptides and single amino acid residues.
To determine whether HOCl modifies MMP-7 at specific sites, we exposed MMP-7 to a concentration of oxidant (50:1, mol/mol, oxidant/protein) that resulted in ~80% inhibition of the enzyme, and then analyzed a tryptic digest of the enzyme by LC-MS. When the oxidant was 3D ). These observations demonstrate that HOCl generated by the myeloperoxidase-H 2 O 2 -Cl -system, but not H 2 O 2 alone, converts the alkylated thiol group of the methionine residue in peptide 8 of MMP-7 to the sulfoxide. LC-MS and MS/MS analysis indicated that the tryptophan residue adjacent to this methionine residue remained intact.
HOCl converts peptide 10 to four major products. Peptide 10 (VVWGTADIMIGFAR) also contains tryptophan and methionine residues that might be vulnerable to HOCl. We therefore used LC-MS and MS/MS to determine the relative abundance of peptide 10 and its potential oxidation products in tryptic digests of untreated MMP-7 and MMP-7 exposed to oxidant. MS/MS analysis confirmed the sequence of doubly protonated peptide 10 in the digest of unmodified MMP-7 (Fig. 4A) . The relative abundance of this peptide ( Fig. 2A,B ) changed little when MMP-7 was exposed to H 2 O 2 alone. In contrast, when MMP-7 was exposed to HOCl or to H 2 O 2 supplemented with myeloperoxidase, peptide 10 disappeared and several small peaks of material appeared in the total ion chromatogram of the tryptic digest ( contained methionine and tryptophan-glycine residues, but only the tryptophan residue in peptide 10 was oxidized when MMP-7 was exposed to HOCl. The selective oxidation of tryptophan in this peptide might reflect a site-specific reaction. To investigate this possibility, we synthesized a synthetic peptide, VVWGTA, which duplicates the region of peptide 10 that contains the vulnerable tryptophan residue. However, the peptide presumably lacks the secondary and tertiary structure of that part of the enzyme. After exposing the synthetic peptide to HOCl for 30 min at Collectively, these observations strongly suggest that WG in peptide 10 is susceptible to sitespecific modification by HOCl and that the product lacks 4 amu (WG−4). They also suggest that this peptide can be oxygenated into isomers that contain either one or two oxygen atoms.
When MMP-7 is exposed to HOCl, oxidation of peptide 10 is associated with loss of enzymatic activity. To determine whether oxidation of specific amino acid residues in peptide 8
or peptide 10 might inactivate MMP-7, we examined the relationship between the disappearance of each peptide and loss of proteolytic activity. Because enzyme exposed to high concentrations of oxidant might undergo stochastic oxidative modifications, we focused our studies on MMP-7 that was <90% inactivated. Under these conditions, there should be a linear relationship between loss of proteolytic activity and peptide modification if oxidation played a causal role in regulating enzyme activity.
Peptide 8 disappeared completely from the tryptic digest of MMP-7 exposed to HOCl, but there was little correlation between its loss and the enzyme's proteolytic activity (Fig. 7) . In contrast, loss of peptide 10 was strongly associated with loss of proteolytic activity. These observations indicate that peptide 8 is more sensitive to oxidation than peptide 10 but that its modification does not diminish enzyme activity. In contrast, oxidative modification of peptide 10 is associated with loss of MMP-7 activity and therefore is likely involved in enzyme inactivation.
DISCUSSION
We demonstrated that HOCl generated by myeloperoxidase inactivates MMP-7. Tandem MS analysis of tryptic digests of MMP-7 exposed to HOCl revealed that only two peptides in the catalytic domain of the enzyme are significantly modified under these conditions. Both contained methionine and tryptophan residues known to be sensitive to oxidation. Despite similarities in the peptides' amino acid compositions, different amino acids were selectively modified. In peptide 8, only methionine was oxygenated, but tryptophan was the major target in peptide 10.
Loss of proteolytic activity in MMP-7 exposed to HOCl was strongly associated with When we exposed MMP-7 to HOCl, oxidation of peptide 10-but not of peptide 8-was associated strongly with loss of proteolytic activity. LC-MS and MS/MS analyses of peptide 10 revealed that WG−4 was a major product, but we also detected oxygenated methionine and tryptophan residues. These observations suggest that formation of WG−4-or other oxidation products derived from tryptophan and methionine-inactivate MMP-7. Consistent with this mechanism, H 2 O 2 failed to inactivate MMP-7, and LC-MS analysis demonstrated that neither peptide 8 nor peptide 10 were modified by this oxidant. The methionine in peptide 8 was more sensitive to oxidation by HOCl than was WG in peptide 10, suggesting that the methionine residue could act as an endogenous antioxidant in the proteinase (38) . It is unclear how oxidation of peptide 10 inactivates MMP-7. The enzyme's crystal structure reveals that peptide 10 lies in a region that is far from the active site of the enzyme (39) . In future studies, it will be important to determine the structure of WG−4 and to explore how the novel modified dipeptide and other oxidized amino acids in peptide 10 affect MMP-7 activity.
HOCl produced by myeloperoxidase might not be the only oxidant capable of inactivating MMPs (17, 18, 21) . A related phagocyte enzyme, eosinophil peroxidase, converts bromide ion to hypobromous acid, which modifies tryptophan residues in lipoproteins more efficiently than HOCl (40,41). Other possible candidates include brominating oxidants produced by myeloperoxidase (42, 43) and peroxynitrite, nitrogen dioxide radical, and hypothiocyanate (16, 17, 21, 44) .
We previously showed that HOCl oxygenates the thiol residue of the cysteine switch domain, activating latent MMP-7 (21) . Tandem MS analysis revealed that the cysteine of pro-MMP-7 is the primary target for oxidation at low concentrations of HOCl. However, when pro-MMP-7 was exposed to higher concentrations of HOCl, we also detected WG−4 (data not shown). These observations suggest that the thiol of the cysteine switch domain is the preferred site of oxidation in pro-MMP-7. However, both pro-MMP-7 and MMP-7 become targets for the formation of WG−4 at higher concentrations of HOCl. Thus, oxidants generated by phagocytes in vivo might contribute to both activation and inactivation of MMPs (Scheme 1). Which action predominates might depend on the local concentration of HOCl at a particular time. Because phagocytes store MMPs and myeloperoxidase in secretory compartments, degranulation of these components could create high local concentrations of both enzymes near the cell surface (4, 17, 18) . Because the phagocyte NADPH oxidase is associated with the plasma membrane, production of H 2 O 2 is also localized to the cell surface (45) . Moreover, because pro-MMP-7,
pro-MMP-8 and pro-MMP-9 are activated by low concentrations of HOCl but disabled by higher concentrations of oxidant (11, 20, 21) , traditional enzyme kinetics cannot fully explain the regulation of MMP activity by reactive oxygen species in tissue or extracellular fluids (4).
Instead, regulation is likely to be highly localized both temporally and spatially by rapid local changes in proteinase and oxidant concentrations. By analogy, it is noteworthy that neutrophils produce evanescent "quantum bursts" of pericellular proteolytic activity when activated in vitro (4) . Therefore, regulation of proteolytic activity might depend critically on local concentrations of oxidants and MMPs near the phagocyte surface. 
